Delivery Order SPE2DB20D3103-SPE2DB24FM5Q6
Award Date 2/6/24
Potential Completion Date 2/7/24
Potential Value $2.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $15,047.26 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $6,544.95 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, received a firm fixed price delivery order contract from the U.S. Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract, valued at $3,073.42, has a completion date of February 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals. The contract has a potential value of $4,734.61 and a completion date of March 8, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $3,451.95 by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $6,087.80 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order contract has a performance period through March 8, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp has an existing indefinite delivery contract (IDC) with DLA, with a potential value of up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,120.33 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, has been awarded a $1,521.95 firm fixed price delivery order contract by the Defense Logistics Agency to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $26,881.05 firm fixed price delivery order by the Defense Logistics Agency (DLA). This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $17,701.03 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM5Q6Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,054.39 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals. This delivery order falls under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has no set-aside designation and will be performed in Conshohocken, Pennsylvania with a completion date of February 7, 2024.
Generated 5/7/24, 12:31 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 2/6/24 |